DISCLOSURES: Labopin: Jazz Pharmaceuticals: Honoraria. Bug:Pfizer: Membership on an entity's Board of Directors or advisory committees; Jazz Pharmaceuticals: Honoraria; Hexal: Membership on an entity's Board of Directors or advisory committees; Gilead Sciences: Membership on an entity's Board of Directors or advisory committees, Other: Travel grants; Celgene: Honoraria, Membership on an entity's Board of Directors or advisory committees, Other: travel grants; Sanofi: Other: travel grants; Novartis: Membership on an entity's Board of Directors or advisory committees, Research Funding; Celgene Neovii: Other: travel grant. Mohty:Jazz Pharmaceuticals: Honoraria, Research Funding.
The Disease-Risk Stratification Scheme (DRSS), a Contemporary Risk-Stratification System for Allogeneic Stem Cell Transplantation
Ciceri F.;
2019-01-01
Abstract
DISCLOSURES: Labopin: Jazz Pharmaceuticals: Honoraria. Bug:Pfizer: Membership on an entity's Board of Directors or advisory committees; Jazz Pharmaceuticals: Honoraria; Hexal: Membership on an entity's Board of Directors or advisory committees; Gilead Sciences: Membership on an entity's Board of Directors or advisory committees, Other: Travel grants; Celgene: Honoraria, Membership on an entity's Board of Directors or advisory committees, Other: travel grants; Sanofi: Other: travel grants; Novartis: Membership on an entity's Board of Directors or advisory committees, Research Funding; Celgene Neovii: Other: travel grant. Mohty:Jazz Pharmaceuticals: Honoraria, Research Funding.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
